New startup, licensing Harvard technology, seeks to bring unprecedented resolution and multiplexing power to standard microscopes at very low cost, aiming to transform biomedical discovery and digital pathology.

Startup developing technology from Prof. Robert Howe's lab is currently resident at Harvard Innovation Lab.

New startup, licensing Harvard technology, seeks to develop an extracorporeal medical device that removes infectious pathogens and toxins from circulating blood of sepsis patients.

Editas was formed in November 2013 to develop genomic editing technologies licensed from medical research labs at Harvard University, Massachusetts General Hospital, and the Broad Institute of MIT and Harvard.